000			01921nam a2200301 4500
001			9978
010			_a9780993543432
090			_a9978
100			_a20170310d2016 y0pory50 ba
101			_aeng
200			_aThe global state of harm reduction 2016 _fKatie Stone _gpref. John-Peter Kools, Rick Lines
210			_aLondon _cHarm Reduction International Penal _d2016
215			_a148 p. _cil. _dDigitalizado
300			_aConsultado em 10 de março de 2017 https://www.penalreform.org/resources/ https://www.hri.global/files/2016/11/14/GSHR2016_14nov.pdf
330			_aThe drive to scale-up needle and syringe programmes and opioid substitution therapy for people who inject drugs has stalled, according to a new report released today by Harm Reduction International (HRI).Despite a UN pledge to end AIDS by 2030, no new countries have established needle and syringe programmes (NSP) since 2014. Out of 158 countries where injecting drug use is reported, 68 still do not provide NSP, while opioid substitution therapy (OST) has been initiated in just three new countries (Monaco, Senegal and Kenya), bringing the total to 80.Since 2006 HRI has tracked a slow but steady expansion of services through its biennial Global State of Harm Reduction report. 2016 is the first year where no new countries have initiated NSPs. In some countries NSP and OST site provision has fallen since 2014.
606			_aDIREITO PENITENCIÁRIO _9549
606			_aTERAPIA DE SUBSTITUIÇÃO _910945
606			_aPROGRAMAS DE TRATAMENTO _98719
606			_aÁFRICA _9343797
700			_aSTONE _bKatie _4070 _910946
701			_aKOOLS _bJohn-Peter _4080 _9105593
701			_aLINES _bRick _4080 _9158354
852			_j343.8STO